Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Given breast cancer, does breast size matter? Data from a prospective breast cancer cohort.

Markkula A, Bromée A, Henningson M, Hietala M, Ringberg A, Ingvar C, Rose C, Jernström H.

Cancer Causes Control. 2012 Aug;23(8):1307-16. doi: 10.1007/s10552-012-0008-9. Epub 2012 Jun 14.

PMID:
22695757
2.

Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.

Diel IJ, Kaufmann M, Costa SD, Holle R, von Minckwitz G, Solomayer EF, Kaul S, Bastert G.

J Natl Cancer Inst. 1996 Nov 20;88(22):1652-8.

PMID:
8931609
3.

Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.

Kim KJ, Huh SJ, Yang JH, Park W, Nam SJ, Kim JH, Lee JH, Kang SS, Lee JE, Kang MK, Park YJ, Nam HR.

Jpn J Clin Oncol. 2005 Mar;35(3):126-33.

PMID:
15741302
4.

Stage 0 to stage III breast cancer in young women.

Gajdos C, Tartter PI, Bleiweiss IJ, Bodian C, Brower ST.

J Am Coll Surg. 2000 May;190(5):523-9.

PMID:
10801018
5.

Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.

Touboul E, Buffat L, Belkacémi Y, Lefranc JP, Uzan S, Lhuillier P, Faivre C, Huart J, Lotz JP, Antoine M, Pène F, Blondon J, Izrael V, Laugier A, Schlienger M, Housset M.

Int J Radiat Oncol Biol Phys. 1999 Jan 1;43(1):25-38.

PMID:
9989511
6.

Possibility of conservative local treatment after combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer.

Touboul E, Buffat L, Lefranc JP, Blondon J, Deniaud E, Mammar H, Laugier A, Schlienger M.

Int J Radiat Oncol Biol Phys. 1996 Mar 15;34(5):1019-28.

PMID:
8600084
7.
8.

Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.

Gajdos C, Tartter PI, Estabrook A, Gistrak MA, Jaffer S, Bleiweiss IJ.

J Surg Oncol. 2002 May;80(1):4-11.

PMID:
11967899
9.

Evaluation of vascular endothelial growth factor as a prognostic marker for local relapse in early-stage breast cancer patients treated with breast-conserving therapy.

Moran MS, Yang Q, Goyal S, Harris L, Chung G, Haffty BG.

Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1236-43. doi: 10.1016/j.ijrobp.2010.07.031. Epub 2010 Nov 17.

PMID:
21093162
10.

Serum lipids and outcome of early-stage breast cancer: results of a prospective cohort study.

Bahl M, Ennis M, Tannock IF, Hux JE, Pritchard KI, Koo J, Goodwin PJ.

Breast Cancer Res Treat. 2005 Nov;94(2):135-44.

PMID:
16261412
11.

Low body mass index is an independent predictive factor of local recurrence after conservative treatment for breast cancer.

Marret H, Perrotin F, Bougnoux P, Descamps P, Hubert B, Lefranc T, Le Floch O, Lansac J, Body G.

Breast Cancer Res Treat. 2001 Mar;66(1):17-23.

PMID:
11368406
12.

Combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer: updated results in a series of 120 patients.

Lerouge D, Touboul E, Lefranc JP, Genestie C, Moureau-Zabotto L, Blondon J.

Int J Radiat Oncol Biol Phys. 2004 Jul 15;59(4):1062-73.

PMID:
15234040
13.

Predictors of recurrence for patients with small (one centimeter or less) localized breast cancer (T1a,b N0 M0).

Leitner SP, Swern AS, Weinberger D, Duncan LJ, Hutter RV.

Cancer. 1995 Dec 1;76(11):2266-74.

PMID:
8635031
14.

LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.

Saha B, Zhang N, Naritoku WY, Tsao-Wei DD, Groshen SL, Carlsson G, Larsson L, Gustavsson B, Chaiwun B, Taylor CR, Imam SA.

Anticancer Res. 2004 Jul-Aug;24(4):2391-400.

15.

Locoregional recurrence of breast cancer following mastectomy: always a fatal event? Results of univariate and multivariate analysis.

Willner J, Kiricuta IC, Kölbl O.

Int J Radiat Oncol Biol Phys. 1997 Mar 1;37(4):853-63.

PMID:
9128962
16.

Survivin expression predicts early recurrence in early-stage breast cancer.

Yamashita S, Masuda Y, Kurizaki T, Haga Y, Murayama T, Ikei S, Kamei M, Takeno S, Kawahara K.

Anticancer Res. 2007 Jul-Aug;27(4C):2803-8.

17.

Locoregional failure of postmastectomy patients with 1-3 positive axillary lymph nodes without adjuvant radiotherapy.

Cheng JC, Chen CM, Liu MC, Tsou MH, Yang PS, Jian JJ, Cheng SH, Tsai SY, Leu SY, Huang AT.

Int J Radiat Oncol Biol Phys. 2002 Mar 15;52(4):980-8.

PMID:
11958892
18.

Patients with recurrent breast cancer: does the primary axillary lymph node status predict more aggressive tumor progression?

Rack B, Janni W, Gerber B, Strobl B, Schindlbeck C, Klanner E, Rammel G, Sommer H, Dimpfl T, Friese K.

Breast Cancer Res Treat. 2003 Nov;82(2):83-92.

PMID:
14692652
19.

Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer.

Heimann R, Ferguson D, Powers C, Recant WM, Weichselbaum RR, Hellman S.

J Natl Cancer Inst. 1996 Dec 4;88(23):1764-9.

PMID:
8944007
20.

Management and survival of female breast cancer: results of a national survey by the American College of Surgeons.

Nemoto T, Vana J, Bedwani RN, Baker HW, McGregor FH, Murphy GP.

Cancer. 1980 Jun 15;45(12):2917-24.

PMID:
7388735

Supplemental Content

Support Center